Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management
Hair Loss
Publication
, Chapter
Olsen, EA
January 1, 2021
Acute hair loss during chemotherapy for breast cancer is common and usually reversible, but occasionally this may become persistent after treatment is completed. Endocrine therapy, because of its effect on the synthesis of both androgens and estrogens and the duration of the treatment, may lead to hair loss as well. Either type of persistent hair loss in breast cancer survivors can adversely affect quality of life. This chapter will discuss the types of hair loss seen in breast cancer survivors and what treatments have been shown to be safe and effective in this population of women.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Olsen, E. A. (2021). Hair Loss. In Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management (pp. 279–292). https://doi.org/10.1007/978-3-030-75377-1_18
Olsen, E. A. “Hair Loss.” In Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management, 279–92, 2021. https://doi.org/10.1007/978-3-030-75377-1_18.
Olsen EA. Hair Loss. In: Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management. 2021. p. 279–92.
Olsen, E. A. “Hair Loss.” Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management, 2021, pp. 279–92. Scopus, doi:10.1007/978-3-030-75377-1_18.
Olsen EA. Hair Loss. Common Issues in Breast Cancer Survivors A Practical Guide to Evaluation and Management. 2021. p. 279–292.